Cargando…
Development and validation of genomic predictors of radiation sensitivity using preclinical data
BACKGROUND: Radiation therapy is among the most effective and commonly used therapeutic modalities of cancer treatments in current clinical practice. The fundamental paradigm that has guided radiotherapeutic regimens are ‘one-size-fits-all’, which are not in line with the dogma of precision medicine...
Autor principal: | Manem, Venkata S. K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377977/ https://www.ncbi.nlm.nih.gov/pubmed/34416855 http://dx.doi.org/10.1186/s12885-021-08652-4 |
Ejemplares similares
-
Predicting Organ-Specific Risk Interactions between Radiation and Chemotherapy in Secondary Cancer Survivors
por: Manem, Venkata S.K., et al.
Publicado: (2017) -
Development and Validation of Diffuse Idiopathic Pulmonary Neuroendocrine Hyperplasia Diagnostic Criteria
por: Sazonova, Olga, et al.
Publicado: (2020) -
Unravelling actionable biology using transcriptomic data to integrate mitotic index and Ki-67 in the management of lung neuroendocrine tumors
por: Manem, Venkata S.K., et al.
Publicado: (2021) -
Modeling of Personalized Treatments in Colon Cancer Based on Preclinical Genomic and Drug Sensitivity Data
por: Keil, Marlen, et al.
Publicado: (2021) -
Addendum: Unravelling actionable biology using transcriptomic data to integrate mitotic index and Ki-67 in the management of lung neuroendocrine tumors
por: Manem, Venkata S.K., et al.
Publicado: (2022)